Where does Helperby Therapeutics Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Helperby Therapeutics Limited ranks #21,223 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Helperby Therapeutics Limited hold?

Helperby Therapeutics Limited holds 13 US utility patents granted between 2015 and 2024, spanning 6 technology areas.

What is Helperby Therapeutics Limited's Innovation Score?

Helperby Therapeutics Limited has an Innovation Score of 26.3 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Helperby Therapeutics Limited focus on?

Helperby Therapeutics Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 13 patents, ranking #1,479 of 6,058 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Helperby Therapeutics Limited's patent grant rate increasing or decreasing?

Helperby Therapeutics Limited's recent grant velocity is -70% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Helperby Therapeutics Limited's patents?

Helperby Therapeutics Limited's patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Helperby Therapeutics Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Helperby Therapeutics Limited

USPTO PatentsView assignee record - 13 granted patents across 6 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Helperby ranks #21,223 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 6 technology areas.

#21,223
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.3/100): 12.0
avg claims per patent: -70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21223 · Foreign Corporation #21,223 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,223/49,997
PHOTO-FINISH Harl-Bella Holdings
CPC-NARROW A61P · 6 areas
INNOV-THIN 26.3/100
CLAIMS-RICH 12.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Harl-Bella Holdings, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Helperby’s 26.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (35%) Velocity 1.3 pts (5%) Breadth 8.7 pts (33%) Claim depth 7.2 pts (27%)

Qualcomm Incorporated · highest

85
Exaptive · near

26
Helperby Therapeutics · this assignee

26
Nano-Master · near

26
The Libman · near

26
BCR Environmental · near

26
3D Lighting… · lowest

7

What this shows Helperby's Innovation Score is 26.3/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Helperby?

Each dot is one of Helperby’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Helperby’s own 12.0 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Helperby vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Helperby's grants concentrate

Helperby Therapeutics Limited is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2018. By volume, Helperby sits between Harl-Bella Holdings, LLC and Highland Industries, LLC.

Helperby's three-year grant acceleration

Helperby Therapeutics Limited shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Harl-bella Holdin…

13
Harman Profession…

13
Harvey Water Soft…

13
Healthpartners Re…

13
Hesai Photonics T…

13
Heye International

13
Hiti Digital

13
Highland Industri…

13
Helperby Therapeu… ◀

13

What this shows Helperby holds 13 patents at rank #21,230, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Helperby

By rank, the assignees closest to #21,230 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Helperby's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Helperby, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Helperby ranks #1,479 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (26 here).

Nano-Master, Inc. 26 The Libman Company 26 Exaptive, Inc. 26 BCR Environmental Corporation 26

Helperby's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Helperby Therapeutics Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	15.4%
2017	4	30.8%
2018	1	7.7%
2019	3	23.1%
2020	1	7.7%
2021	1	7.7%
2024	1	7.7%

Which technologies does Helperby Therapeutics Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

Y02A - Technologies FOR Adaptation TO Climate Change 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

C07D - Heterocyclic Compounds 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Helperby Therapeutics Limited's patent record in context - here's where to go next.

Helperby Therapeutics Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #21,223 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Helperby Therapeutics Limited against Harl-Bella Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.